Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S, Bay J, Franz AR, Erhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L; NeoVitaA trial investigators. Meyer S, et al. Among authors: bottger r. Lancet Respir Med. 2024 Apr 18:S2213-2600(24)00073-0. doi: 10.1016/S2213-2600(24)00073-0. Online ahead of print. Lancet Respir Med. 2024. PMID: 38643780
A Novel Leu-Enkephalin Prodrug Produces Pain-Relieving and Antidepressant Effects.
Hohenwarter L, Puil E, Rouhollahi E, Bohrmann L, Lu S, Saatchi K, Häfeli UO, Barr A, Böttger R, Viswanadham KKD, Li SD. Hohenwarter L, et al. Among authors: bottger r. Mol Pharm. 2024 Feb 5;21(2):688-703. doi: 10.1021/acs.molpharmaceut.3c00807. Epub 2024 Jan 20. Mol Pharm. 2024. PMID: 38243899
Similar adverse outcome rates with high or low oxygen saturation targets in an area with low background mortality.
Willgerodt N, Bührer C, Rossi R, Kühn T, Rüdiger M, Avenarius S, Böttger R, Olbertz DM, Proquitte H, Bittrich HJ, Haase R, Fröhlich M, Höhne S, Thome UH. Willgerodt N, et al. Among authors: bottger r. Front Pediatr. 2023 Oct 24;11:1235877. doi: 10.3389/fped.2023.1235877. eCollection 2023. Front Pediatr. 2023. PMID: 37941976 Free PMC article.
Modification and Delivery of Enkephalins for Pain Modulation.
Hohenwarter L, Böttger R, Li SD. Hohenwarter L, et al. Among authors: bottger r. Int J Pharm. 2023 Nov 5;646:123425. doi: 10.1016/j.ijpharm.2023.123425. Epub 2023 Sep 20. Int J Pharm. 2023. PMID: 37739096 Review.
Search for 22Na in novae supported by a novel method for measuring femtosecond nuclear lifetimes.
Fougères C, de Oliveira Santos F, José J, Michelagnoli C, Clément E, Kim YH, Lemasson A, Guimarães V, Barrientos D, Bemmerer D, Benzoni G, Boston AJ, Böttger R, Boulay F, Bracco A, Čeliković I, Cederwall B, Ciemala M, Delafosse C, Domingo-Pardo C, Dudouet J, Eberth J, Fülöp Z, González V, Gottardo A, Goupil J, Hess H, Jungclaus A, Kaşkaş A, Korichi A, Lenzi SM, Leoni S, Li H, Ljungvall J, Lopez-Martens A, Menegazzo R, Mengoni D, Million B, Mrázek J, Napoli DR, Navin A, Nyberg J, Podolyák Z, Pullia A, Quintana B, Ralet D, Redon N, Reiter P, Rezynkina K, Saillant F, Salsac MD, Sánchez-Benítez AM, Sanchis E, Şenyiğit M, Siciliano M, Smirnova NA, Sohler D, Stanoiu M, Theisen C, Valiente-Dobón JJ, Ujić P, Zielińska M. Fougères C, et al. Among authors: bottger r. Nat Commun. 2023 Sep 5;14(1):4536. doi: 10.1038/s41467-023-40121-3. Nat Commun. 2023. PMID: 37669984 Free PMC article.
Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence-Based Vascular Severity Score.
Eilts SK, Pfeil JM, Poschkamp B, Krohne TU, Eter N, Barth T, Guthoff R, Lagrèze W, Grundel M, Bründer MC, Busch M, Kalpathy-Cramer J, Chiang MF, Chan RVP, Coyner AS, Ostmo S, Campbell JP, Stahl A; Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP) Study Group. Eilts SK, et al. JAMA Netw Open. 2023 Jan 3;6(1):e2251512. doi: 10.1001/jamanetworkopen.2022.51512. JAMA Netw Open. 2023. PMID: 36656578 Free PMC article. Clinical Trial.
75 results